Unknown

Dataset Information

0

Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey.


ABSTRACT: The etiology of bacterial meningitis in Turkey changed after the implementation of conjugated vaccines against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) in the Turkish National Immunization Program (NIP). Administration of Hib vaccine and PCV-7 (7-valent pneumococcal conjugate vaccine) was implemented in NIP in 2006 and 2009, respectively. In 2011, PCV-7 was replaced with PCV-13. Meningococcal vaccines have not yet been included in Turkish NIP. This prospective study comprised 27 hospitals located in seven regions of Turkey and represented 45% of the population. Children aged between 1?month and 18?years who were hospitalized with suspected meningitis were included. Cerebrospinal fluid (CSF) samples were collected, and bacterial identification was made according to the multiplex PCR assay results. During the study period, 994 children were hospitalized for suspected meningitis, and Hib (n?=?3, 2.4%), S. pneumoniae (n?=?33, 26.4%), and Neisseria meningitidis (n?=?89, 71%) were detected in 125 samples. The most common meningococcal serogroup was MenB. Serogroup W comprised 13.9% (n?=?5) and 7.5% (n?=?4) of the meningococci in 2015 to 2016 and 2017 to 2018, respectively. Serogroup C was not detected. There were four deaths in the study; one was a pneumococcus case, and the others were serogroup B meningococcus cases. The epidemiology of meningococcal diseases has varied over time in Turkey. Differing from the previous surveillance periods, MenB was the most common serogroup in the 2015-to-2018 period. Meningococcal epidemiology is so dynamic that, for vaccination policies, close monitoring is crucial.IMPORTANCE Acute bacterial meningitis (ABM) is one of the most common life-threatening infections in children. The incidence and prevalence of ABM vary both geographically and temporally; therefore, surveillance systems are necessary to determine the accurate burden of ABM. The Turkish Meningitis Surveillance Group has been performing a hospital-based meningitis surveillance study since 2005 across several regions in Turkey. Meningococcus was the major ABM-causing agent during the 2015-to-2018 period, during which MenB was the dominant serogroup.

SUBMITTER: Ceyhan M 

PROVIDER: S-EPMC7096621 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey.

Ceyhan Mehmet M   Ozsurekci Yasemin Y   Tanır Basaranoglu Sevgen S   Gurler Nezahat N   Sali Enes E   Keser Emiroglu Melike M   Oz Fatma Nur FN   Belet Nursen N   Duman Murat M   Ulusoy Emel E   Kurugol Zafer Z   Tezer Hasan H   Ozkaya Parlakay Aslinur A   Dinleyici Ener Cagri EC   Celik Umit U   Celebi Solmaz S   Oner Ahmet Faik AF   Solmaz Mehmet Ali MA   Karbuz Adem A   Hatipoglu Nevin N   Devrim Ilker I   Caglar Ilknur I   Bozdemir Sefika Elmas SE   Kocabas Emine E   Gundeslioglu Ozlem Ozgur OO   Sutcu Murat M   Metin Akcan Ozge O   Kuyucu Necdet N   Aktar Fesih F   Kara Soner Sertan SS   Altay Akisoglu Havva Ozlem HO   Tuygun Nilden N   Tamburaci Uslu Zeynep Diyar ZD   Karadag Oncel Eda E   Bayhan Cihangul C   Cengiz Ali Bulent AB  

mSphere 20200325 2


The etiology of bacterial meningitis in Turkey changed after the implementation of conjugated vaccines against <i>Streptococcus pneumoniae</i> and <i>Haemophilus influenzae</i> type b (Hib) in the Turkish National Immunization Program (NIP). Administration of Hib vaccine and PCV-7 (7-valent pneumococcal conjugate vaccine) was implemented in NIP in 2006 and 2009, respectively. In 2011, PCV-7 was replaced with PCV-13. Meningococcal vaccines have not yet been included in Turkish NIP. This prospecti  ...[more]

Similar Datasets

| S-EPMC3426078 | biostudies-literature
| S-EPMC5512487 | biostudies-literature
| S-EPMC87969 | biostudies-literature
| S-EPMC3457995 | biostudies-literature
| S-EPMC10077696 | biostudies-literature
| S-EPMC6082507 | biostudies-literature
| S-EPMC9315783 | biostudies-literature
| S-EPMC4514299 | biostudies-literature
| S-EPMC1865605 | biostudies-literature
| S-EPMC9427638 | biostudies-literature